Hosein Kouros-Mehr: I’m starting a new position as Senior Vice President at Myriad Genetics
Hosein Kouros-Mehr, Senior Vice President at Myriad Genetics, shared a post on LinkedIn:
“I’m happy to share that I’m starting a new position as Senior Vice President at Myriad Genetics!
Thirty years after cloning BRCA1, Myriad Genetics is re-emerging as a major innovator in oncology with products spanning the cancer patient journey, from germline and somatic tumor testing to companion diagnostics, prognostic products, and ultra-sensitive MRD testing.
I look forward to partnering with my colleagues in biotech and pharma to improve the success rate of cancer clinical trials and delivering on the promise of personalized medicine. Most of all, I look forward to helping doctors and patients with better tools designed to prevent, diagnose, and manage cancer.
We can’t develop the next wave of cancer medicines without next-generation cancer diagnostics. The journey continues!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023